FDA approvalconf 0.70
FDA approval
$SVRA · Savara Inc
Event date
Date TBD
Sponsor runway
18 mo
$202.8M liquid
Evidence
Comparable historical fda approvals· last 5 years · same event type
100% hit rate (10/10)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $INCY | zynyz | 2026-05-18 | success |
| $INCY | jakafi xr | 2026-05-01 | success |
| $AXSM | auvelity | 2026-04-30 | success |
| $INCY | zynyz | 2026-03-30 | success |
| $BIIB | spinraza | 2026-03-27 | success |
| $CORT | lifyorli | 2026-03-25 | success |
| $RYTM | imcivree | 2026-03-19 | success |
| $ASND | yuviwel | 2026-02-27 | success |
| $BMRN | palynziq | 2026-02-27 | success |
| $ETON | desmoda | 2026-02-25 | success |
Recent insider activity· ±90 days
1 insider · 0 buys · 0 sells
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
80,684 @ $1.51$122K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
24,174 @ $5.04$122K
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
75,000 @ $1.59$119K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
23,661 @ $5.04$119K
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
130,650 @ $1.23$161K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
31,885 @ $5.04$161K
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
43,063 @ $1.11$48K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
9,485 @ $5.04$48K
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
12,500 @ $4.45$56K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
11,037 @ $5.04$56K
Exercise
2026-03-18Lowrance David L
Chief Financial Officer
24,850 @ $3.35$83K
Tax
2026-03-18Lowrance David L
Chief Financial Officer
16,518 @ $5.04$83K